Quick urine test could spot HIV pill problems before virus rebounds
NCT ID NCT05333679
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new urine-based rapid test (UTRA) that checks if people with HIV are taking their medication tenofovir as prescribed. The goal is to catch adherence problems early, before the virus level in blood rises. Researchers compared the urine test results with blood drug levels, self-reports, and pharmacy records in 200 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
urine tenofovir rapid assay (UTRA) test
What this could lead to
If successful, this test could help clinics identify adherence problems early and provide timely support, keeping HIV suppressed.
What could go wrong
This is a completed study with 200 participants, so results are limited in size and may not apply to all settings. The test only checks for one medication (tenofovir) and may miss other adherence issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Desmond Tutu Health Foundation, University of Cape Town
Cape Town, Western Cape, 7925, South Africa